Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - hydroxychloroquine sulfate - film-coated tablet - 200 milligram(s) - hydroxychloroquine

United States - English - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - hydroxychloroquine sulfate (unii: 8q2869cnvh) (hydroxychloroquine - unii:4qwg6n8qkh) - hydroxychloroquine sulfate tablets, usp are indicated for the treatment of uncomplicated malaria due to p. falciparum , p. malariae , p. ovale , and p. vivax .   hydroxychloroquine sulfate tablets, usp are indicated for the prophylaxis of malaria in geographic areas where chloroquine resistance is not reported. limitations of use in malaria   - hydroxychloroquine sulfate tablets, usp are not recommended for the treatment of complicated malaria. - hydroxychloroquine sulfate tablets, usp are not effective against chloroquine or hydroxychloroquine-resistant strains of plasmodium species (seeclinical pharmacology – microbiology) . hydroxychloroquine sulfate tablets, usp are not recommended for the treatment of malaria acquired in geographic areas where chloroquine resistance occurs or when the plasmodium species has not been identified. - hydroxychloroquine sulfate tablets, usp are not recommended for malaria prophylaxis in geographic areas where chloroquine